ONCUSP Trademark

Trademark Overview

On Monday, February 15, 2021, a trademark application was filed for ONCUSP with the United States Patent and Trademark Office. The USPTO has given the ONCUSP trademark a serial number of 90529790. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, September 6, 2022. The ONCUSP trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the prevention and treatment of cancer
oncusp

General Information

Serial Number90529790
Word MarkONCUSP
Filing DateMonday, February 15, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, September 6, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 19, 2021

Trademark Statements

Goods and ServicesPharmaceutical products for the prevention and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 11, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressNew York, NY 10013
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressPrinceton, NJ 08540

Trademark Events

Event DateEvent Description
Tuesday, September 6, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, September 6, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, September 6, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, February 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 11, 2022NON-FINAL ACTION E-MAILED
Friday, February 11, 2022SU - NON-FINAL ACTION - WRITTEN
Friday, February 4, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 4, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 3, 2022ASSIGNED TO LIE
Tuesday, February 1, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 1, 2022NON-FINAL ACTION E-MAILED
Tuesday, February 1, 2022SU - NON-FINAL ACTION - WRITTEN
Saturday, January 15, 2022STATEMENT OF USE PROCESSING COMPLETE
Monday, December 27, 2021USE AMENDMENT FILED
Saturday, January 15, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 27, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, December 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 19, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 19, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 29, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 10, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 9, 2021ASSIGNED TO EXAMINER
Tuesday, May 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 18, 2021NEW APPLICATION ENTERED IN TRAM

Related Keywords

oncusp cancer treatment prevention products pharmaceutical